Seres Therapeutics Inc (1S9.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
As of 08:01AM CEST. Market open.
| Previous Close | 0.8510 |
| Open | 0.8170 |
| Bid | 0.8170 x 100000 |
| Ask | 0.9166 x 100000 |
| Day's Range | 0.8170 - 0.8170 |
| 52 Week Range | 0.4971 - 5.7000 |
| Volume | |
| Avg. Volume | 1,528 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Insider MonkeySeres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript May 11, 2024 Seres Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name is Alex, and I will be your conference operator today. […]
Simply Wall St.Seres Therapeutics First Quarter 2024 Earnings: US$0.28 loss per share (vs US$0.56 loss in 1Q 2023)
Seres Therapeutics ( NASDAQ:MCRB ) First Quarter 2024 Results Key Financial Results Net loss: US$40.1m (loss narrowed...
- GuruFocus.com
Seres Therapeutics Inc (MCRB) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
Unveiling key financial results and strategic directions, including the impactful launch of VOWST and promising developments in SER-155.
© 2024 Yahoo. All rights reserved.